Pelago

New York, New York, USA · ≈180 employees · pelagohealth.com

Pelago is a leading virtual clinic specializing in substance use care, offering personalized support for tobacco, alcohol, opioid, cannabis, and stimulant use. Founded in 2017, Pelago partners with employers and health plans to provide discreet, evidence-based treatment for individuals facing substance dependence. The company operates a fully digital behavioral therapy platform that includes Cognitive Behavioral Therapy (CBT), Medication-Assisted Treatment (MAT), and live counseling. Users can access animated videos, interactive exercises, and audio sessions to understand their addiction triggers. They also receive clinical medications managed by licensed providers and have 24/7 access to licensed clinicians through a care hotline and video sessions. Pelago's integrated care model is backed by published, peer-reviewed evidence demonstrating its clinical impact and cost savings for organizations. Headquartered in New York, with additional offices in San Francisco and London, Pelago serves over 4 million people globally. The company has raised $151 million in funding, including a $58 million Series C round in 2024, and employs approximately 169 people.